| Literature DB >> 32153702 |
Zayid Al Mayahi1, Shady Kamel1,2, Hala Amer3,4, Mark Beatty1.
Abstract
INTRODUCTION: Multidrug-resistant organisms (MDROs) have been a major concern in King Saud Medical City (KSMC) recently. The number of cases with colistin resistance was growing rapidly in the first half of 2016, challenging the infection control practices and mandating a thorough outbreak investigation. The objective of this study was to determine the extent of the outbreak, identify potential risk factors and prevent further increase in the rates of MDROs.Entities:
Keywords: Colistin resistance; KSA; MDROs; antibiotics; multidrug resistant organisms
Mesh:
Substances:
Year: 2019 PMID: 32153702 PMCID: PMC7046114 DOI: 10.11604/pamj.2019.34.162.19998
Source DB: PubMed Journal: Pan Afr Med J
Characteristics of patients with colistin resistant organisms (n=22)
| Characteristic | Number (n=22) | % |
|---|---|---|
| <40 year | 7 | 31.8 |
| 40 – 60 | 8 | 36.4 |
| > 60 year | 7 | 31.8 |
| Range | 20-79 | |
| Mean+SD | 49.71 + 17.824 | |
| Male | 20 | 90.9 |
| Female | 2 | 9.1 |
| Medical | 14 | 63.6 |
| Surgical | 8 | 36.4 |
| Through Emergency Department | 20 | 90.9 |
| Direct referral from other hospitals | 2 | 9.1 |
| Less than 24 hours | 9 | 40.9 |
| One day | 10 | 45.5 |
| Two days | 1 | 4.5 |
| Three days and more | 2 | 9.0 |
| Mean +SD | 1.23 + 2.525 | |
| Yes | 5 | 22.7 |
| No | 17 | 77.3 |
| Yes | 12 | 54.5 |
| No | 10 | 45.5 |
Figure 1The structure of the intensive care unit
Distribution of sites of infection and cultures sampled
| Site of infection | Samples | Total Number N=131 | Percentage of patients on devices N=22 | ||
|---|---|---|---|---|---|
| Type | Number (131) | % | |||
| Respiratory tract | Sputum | 41 | 31.3 | 54 (41.3 %) | Ventilator 21 (95.5%) |
| Tracheal aspirate | 12 | 9.2 | |||
| Pleural fluid | 1 | 0.8 | |||
| Bronchial wash | 1 | 0.8 | |||
| Soft, skin, tissue | Soft, skin & tissue | 28 | 21.4 | 28 (21.4%) | |
| Blood stream | Blood | 28 | 21.4 | 29 (22.1%) | |
| Urine tract | Urinary catheter | 11 | 8.4 | 19 (14.5%) | Urinary catheter |
| Urine | 8 | 6.1 | 21 (95.5%) | ||
| CSF | CSF | 1 | 0.8 | 1 (0.8%) | |
Characteristics of resistant organisms of 131 cultures
| Variables | Number (n=131) | % |
|---|---|---|
| Gram negative | 103 | 78.6 |
| Gram Positive | 28 | 21.4 |
| Resistance to at least one AB | 108 | 82.4 |
| Multidrug Resistant Organism | 31 | 23.7 |
| MRSA | 9 | 6.9 |
| VRE | 1 | 0.8 |
| CRE | 20 | 15.3 |
| ESBL | 18 | 13.7 |
| Yes | 87 | 66.4 |
| No | 41 | 31.3 |
| Unavailable | 3 | 2.3 |
Frequency of antibiotics resistance
| Drug | Resistance/Administration | % |
|---|---|---|
| Cefotaxime | 8 (8) | 100 |
| Tazocin | 11(13) | 84.6 |
| Ceftazidime | 39(47) | 83 |
| Ceftriaxone | 23(28) | 82 |
| Ciprofloxacin | 75(95) | 79 |
| Imipenem | 50(64) | 78.1 |
| Oxacillin | 13(17) | 76.5 |
| Nitrofurantoin | 8(11) | 72.7 |
| Gentamicin | 50(79) | 63.3 |
| Meropenem | 51(82) | 62.2 |
| Cotrimox | 55(94) | 58.5 |
| Amikacin | 37(79) | 46.8 |
| Colistin | 23(53) | 43.4 |
| Tigecycline | 5(13) | 38.5 |
| Clindamycin | 4(11) | 36.4 |
| Cefepime | 12(37) | 32.4 |
| (Ampicillin, Amoxicillin) | 1(7) | 14.3 |
| Vancomycin | 1(13) | 0.08 |